Skip to content
Tenfell
Awarded contract
Published 13 Apr 2022

Requirement for producer cell line for GMP viral vector packaging

NHS Blood and Transplant · United Kingdom

Key facts

Contract value
£111,000
Awarded
06 Apr 2022
Contract starts
06 Apr 2022
Contract ends
05 Apr 2024
Procedure
Open procedure (above threshold)
Buyer type
Health

Awarded to

SupplierValue
Life Technologies Ltd£111,000

Description

NHSBT's Clinical Biotechnology Centre for the purpose of specifying the user requirement for HEK293-derived production cell line for the GMP-production of viral vectors and other recombinant proteins. The CBC has an MHRA licence for the manufacture of investigational medicinal gene therapy and recombinant protein products for use in clinical trials. In order to manufacture GMP-grade viral vectors and recombinant proteins for clinical trials, a GMP-qualified producer cell line is required.

Categories (CPV)

Similar open tenders

About NHS Blood and Transplant

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.